BCRX
Biocryst Pharm (BCRX)
NASDAQ
$7.79+$0.04 (+0.45%)
Price as of Oct 22, 2026 7:30 PM EDT
  • $2.0B
    Market Cap
  • 9.46%
    1-Year Change
  • Drug Manufacturers - Specialty & Generic
    Industry

Earnings Score

Score: 42
Valuation
BCRX
vs History
vs S&P 500
Profitability
-0
Growth
-0
Low Earnings Volatility
2

Momentum Score

Score: 69
Valuation
BCRX
vs History
vs S&P 500
3-Month Momentum
-6.79%
12-Month Momentum
25.70%
3-Month Risk Adjusted Momentum
-34.67%
12-Month Risk Adjusted Momentum
55.29%

True Yield

N/A
Valuation
BCRX
vs History
vs S&P 500
Dividend Yield
N/A
Net Buyback Yield
-1.14%
Net Debt Paydown Yield
-0.01%

Financial Health Score

Score: 39
Valuation
BCRX
vs History
vs S&P 500
Ohlson's O-Score
2